PB
Highly rated in
8
conditions

Dr. Peter E. Bressler

North Texas Endocrine Center
Dallas, TX
Highly rated in
8
conditions
Specialties:Endocrinology
Experience:36 Years
Clinical Trials:Currently Recruiting for 3 Trials
Accepts:New PatientsMedicare
Highly rated in
8
conditions
About|Expertise|Insurance|Location|Research
Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

      View 15 More Conditions +
      Check Dr. Peter E. Bressler's experience treating your condition:
      About Dr. Peter E. Bressler

      Peter Bressler is an Endocrinologist in Dallas, Texas. Bressler has been practicing medicine for over 36 years and is highly rated in 8 conditions, according to our data. His top areas of expertise are Hashimoto Thyroiditis, Type 2 Diabetes (T2D), Thyroid Cancer, and Papillary Thyroid Cancer. He is licensed to treat patients in Texas. Bressler is currently accepting new patients.

      His participating in 8 clinical trials in the past 15 years.

      Insurance

      MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Peter E. Bressler it is best to call his office and ask if your insurance is accepted.

      Accepts Medicare

      Dr. Peter E. Bressler accepts the following insurance:

      •  Ambetter
      Call to see if your plan is accepted.
      Locations
      9301 N Central Expy, #570, Dallas, TX 75231
      Background & Education
      Graduate Institution
      University Of Arizona College Of Medicine, 1987
      Specialties
      Endocrinology
      Licenses
      Internal Medicine in TX
      Hospital Affiliations
      Texas Health Plano
      Medical City Lewisville
      Medical City Dallas
      Texas Health Dallas
      Medical City Plano
      William P Clements Jr University Hospital
      Baylor Scott & White Medical Center - Plano
      Languages Spoken
      English
      Spanish
      Gender
      Male
      Clinical Research

      Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

      7 Clinical Trials
      A Phase 3, Multicenter, Randomized, Parallel-Design, Open-Label Study to Evaluate the Efficacy and Safety of LY3209590 as a Weekly Basal Insulin Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection Therapy
      Enrollment Status: Recruiting
      Publish Date: December 12, 2022
      Intervention Type: Drug
      Study Phase: Phase 3
      A Phase 3, Parallel-Design, Open-Label, Randomized Controlled Study to Evaluate the Efficacy and Safety of LY3209590 as a Weekly Basal Insulin Compared to Insulin Glargine in Adults With Type 2 Diabetes on Multiple Daily Injections
      Enrollment Status: Recruiting
      Publish Date: December 12, 2022
      Intervention Type: Drug
      Study Phase: Phase 3
      A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of the Efficacy, Safety, and Pharmacokinetics of Two Doses of INV-202 in Patients With Diabetic Kidney Disease
      Enrollment Status: Recruiting
      Publish Date: December 02, 2022
      Intervention Type: Drug
      Study Phase: Phase 2
      Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo for Maintenance of Weight Loss in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight-Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-4)
      Enrollment Status: Active, not recruiting
      Publish Date: December 12, 2022
      Intervention Type: Other, Drug
      Study Drug: Tirzepatide
      Study Phase: Phase 3
      The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
      Enrollment Status: Active, not recruiting
      Publish Date: December 12, 2022
      Intervention Type: Drug
      Study Drugs: TirzepatideDulaglutide
      Study Phase: Phase 3
      A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With Established Cardiovascular Disease
      Enrollment Status: Active, not recruiting
      Publish Date: October 10, 2022
      Intervention Type: Drug
      Study Drug: TQJ230
      Study Phase: Phase 3
      Efficacy and Safety of Tirzepatide Once Weekly in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight- Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-1)
      Enrollment Status: Active, not recruiting
      Publish Date: April 13, 2022
      Intervention Type: Drug
      Study Drug: Tirzepatide
      Study Phase: Phase 3
      View 4 Less Clinical Trials -
      Save this doctor for later
      Sign Up
      Looking for the best doctor for you?
      Start Here
      Is this your doctor?
      Find a second opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn more
      Similar Doctors
      AG
      Dr. Abhimanyu Garg
      Endocrinology
      Highly rated in
      14
      conditions
      Endocrinology

      Internal Medicine Subspecialties Clinic At West Campus Building 3

      2001 Inwood Rd, 
      Dallas, TX 
       5.9 mi

      Abhimanyu Garg is an Endocrinologist in Dallas, Texas. Garg has been practicing medicine for over 42 years and is highly rated in 14 conditions, according to our data. His top areas of expertise are Congenital Generalized Lipodystrophy, Familial Partial Lipodystrophy, Gigantism, Familial Hypertriglyceridemia, and Gastric Bypass. He is licensed to treat patients in Texas. Garg is currently accepting new patients.

      ZA
      Dr. Zahid S. Ahmad
      Endocrinology
      Highly rated in
      8
      conditions
      Endocrinology

      Internal Medicine Subspecialties Clinic At West Campus Building 3

      2001 Inwood Rd, 
      Dallas, TX 
       5.9 mi

      Zahid Ahmad is an Endocrinologist in Dallas, Texas. Ahmad has been practicing medicine for over 19 years and is highly rated in 8 conditions, according to our data. His top areas of expertise are Familial Hypercholesterolemia, Familial Hypertriglyceridemia, Apolipoprotein C2 Deficiency, and Familial Lipoprotein Lipase Deficiency. He is licensed to treat patients in Texas. Ahmad is currently accepting new patients.

      JR
      Dr. Julio Rosenstock
      Endocrinology
      Highly rated in
      6
      conditions
      Endocrinology

      HCA Medical City Healthcare

      7777 Forest Ln, 
      Dallas, TX 
       2.6 mi

      Julio Rosenstock is an Endocrinologist in Dallas, Texas. Rosenstock has been practicing medicine for over 48 years and is highly rated in 6 conditions, according to our data. His top areas of expertise are Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Low Blood Sugar, and Obesity. He is licensed to treat patients in Texas.